Literature DB >> 3308964

Immunocytochemical analysis of HLA class II (DR) antigens in liver disease in man.

C Barbatis1, P Kelly, J Greveson, A Heryet, J O McGee.   

Abstract

The in situ distribution of the major histocompatibility (HLA) class II (DR) antigens was studied in 113 liver biopsy specimens and five livers obtained at necropsy, using monoclonal antibody CR3/43. In 20 normal livers HLA-DR antigens were not detected in bile duct epithelium, hepatocytes, or portal vein endothelium. Normal arteriolar, sinusoidal and central venous endothelium often expressed HLA-DR. Kupffer cells always expressed these antigens. HLA-DR positive spindle cells were identified in the connective tissue of portal tracts, large hepatic veins, and liver capsule: most shared antigens common to all leucocytes and reacted with the histiocytic maker EBM11. Bile duct epithelium expresses HLA-DR in primary biliary cirrhosis, large duct obstruction, and drug induced cholestasis, indicating that HLA-DR positive spindle cells are phenotypically similar to histiocytes.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3308964      PMCID: PMC1141129          DOI: 10.1136/jcp.40.8.879

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  32 in total

1.  Diet and antibody response to vaccinations in healthy infants.

Authors:  G Zoppi; R Gasparini; F Mantovanelli; L Gobio-Casali; R Astolfi; P Crovari
Journal:  Lancet       Date:  1983-07-02       Impact factor: 79.321

2.  Expression of Ia antigen on epidermal keratinocytes is a consequence of cellular immunity.

Authors:  A J Suitters; I A Lampert
Journal:  Br J Exp Pathol       Date:  1982-04

3.  Expression of Ia antigen on epidermal keratinocytes in graft-versus-host disease.

Authors:  I A Lampert; A J Suitters; P M Chisholm
Journal:  Nature       Date:  1981 Sep 10-16       Impact factor: 49.962

4.  Distribution of the major histocompatibility complex antigens on different cellular components of human liver.

Authors:  I Lautenschlager; E Taskinen; K Inkinen; V P Lehto; I Virtanen; P Häyry
Journal:  Cell Immunol       Date:  1984-04-15       Impact factor: 4.868

5.  Expression of HLA-DR antigens by colonic epithelium in inflammatory bowel disease.

Authors:  W S Selby; G Janossy; D Y Mason; D P Jewell
Journal:  Clin Exp Immunol       Date:  1983-09       Impact factor: 4.330

6.  Human keratinocytes express HLA-DR antigens in the tuberculin reaction.

Authors:  A Scheynius; U Tjernlund
Journal:  Scand J Immunol       Date:  1984-02       Impact factor: 3.487

7.  Interdigitating and dendritic reticulum cells in chronic active hepatitis.

Authors:  K A Bardadin; V J Desmet
Journal:  Histopathology       Date:  1984-07       Impact factor: 5.087

8.  Giant cell myocarditis: evidence for the macrophage origin of the giant cells.

Authors:  J M Theaker; K C Gatter; A Heryet; D J Evans; J O McGee
Journal:  J Clin Pathol       Date:  1985-02       Impact factor: 3.411

9.  Aberrant expression of HLA-DR antigens on bileduct epithelium in primary biliary cirrhosis: relevance to pathogenesis.

Authors:  G Ballardini; R Mirakian; F B Bianchi; E Pisi; D Doniach; G F Bottazzo
Journal:  Lancet       Date:  1984-11-03       Impact factor: 79.321

10.  Ia expression by vascular endothelium is inducible by activated T cells and by human gamma interferon.

Authors:  J S Pober; M A Gimbrone; R S Cotran; C S Reiss; S J Burakoff; W Fiers; K A Ault
Journal:  J Exp Med       Date:  1983-04-01       Impact factor: 14.307

View more
  10 in total

1.  A Christmas thought from Professor NA Wright: HLA-DR expression in liver disease.

Authors:  N Wright
Journal:  J Clin Pathol       Date:  1987-12       Impact factor: 3.411

Review 2.  Mitochondrial antigens and antibodies in primary biliary cirrhosis.

Authors:  P Butler; F Valle; A K Burroughs
Journal:  Postgrad Med J       Date:  1991-09       Impact factor: 2.401

3.  Monoclonal antibody EBM/11: high cellular specificity for human macrophages.

Authors:  P M Kelly; E Bliss; J A Morton; J Burns; J O McGee
Journal:  J Clin Pathol       Date:  1988-05       Impact factor: 3.411

Review 4.  ABO-compatible liver allograft antibody-mediated rejection: an update.

Authors:  Anthony J Demetris; Adriana Zeevi; Jacqueline G O'Leary
Journal:  Curr Opin Organ Transplant       Date:  2015-06       Impact factor: 2.640

5.  Biliary expression of heat shock protein: a non-specific feature of chronic cholestatic liver diseases.

Authors:  E B Martins; R W Chapman; K Marron; K A Fleming
Journal:  J Clin Pathol       Date:  1996-01       Impact factor: 3.411

6.  Assessment of Physicochemical and In Vivo Biological Properties of Polymeric Nanocapsules Based on Chitosan and Poly(N-vinyl pyrrolidone-alt-itaconic anhydride).

Authors:  Kheira Zanoune Dellali; Mohammed Dellali; Delia Mihaela Raţă; Anca Niculina Cadinoiu; Leonard Ionut Atanase; Marcel Popa; Mihaela-Claudia Spataru; Carmen Solcan
Journal:  Polymers (Basel)       Date:  2022-04-28       Impact factor: 4.967

7.  Impact of Antibodies That React With Liver Tissue and Donor-Specific Anti-HLA Antibodies in Pediatric Idiopathic Posttransplantation Hepatitis.

Authors:  Yoshihiro Hirata; Atsushi Yoshizawa; Hiroto Egawa; Daisuke Ueda; Shinya Okamoto; Hideaki Okajima; Kimiko Yurugi; Rie Hishida; Hideyo Hirai; Aya Miyagawa-Hayashino; Taira Maekawa; Hironori Haga; Sinji Uemoto
Journal:  Transplantation       Date:  2017-05       Impact factor: 4.939

8.  Single-cell RNA sequencing of human liver reveals hepatic stellate cell heterogeneity.

Authors:  Valéry L Payen; Arnaud Lavergne; Niki Alevra Sarika; Megan Colonval; Latifa Karim; Manon Deckers; Mustapha Najimi; Wouter Coppieters; Benoît Charloteaux; Etienne M Sokal; Adil El Taghdouini
Journal:  JHEP Rep       Date:  2021-03-21

Review 9.  The immunogenetics of primary biliary cirrhosis: A comprehensive review.

Authors:  G J Webb; K A Siminovitch; G M Hirschfield
Journal:  J Autoimmun       Date:  2015-08-03       Impact factor: 7.094

10.  Therapeutic applications of the selective high affinity ligand drug SH7139 extend beyond non-Hodgkin's lymphoma to many other types of solid cancers.

Authors:  Rod Balhorn; Monique Cosman Balhorn
Journal:  Oncotarget       Date:  2020-09-01
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.